标题
Clinical advances and ongoing trials of mRNA vaccines for cancer treatment
作者
关键词
-
出版物
LANCET ONCOLOGY
Volume 23, Issue 10, Pages e450-e458
出版商
Elsevier BV
发表日期
2022-09-27
DOI
10.1016/s1470-2045(22)00372-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- mRNA vaccine for cancer immunotherapy
- (2021) Lei Miao et al. Molecular Cancer
- mRNA therapeutics in cancer immunotherapy
- (2021) Jan D. Beck et al. Molecular Cancer
- mRNA-Based Vaccines
- (2021) Frank Kowalzik et al. Vaccines
- The tangled history of mRNA vaccines
- (2021) Elie Dolgin NATURE
- Lipid nanoparticles for mRNA delivery
- (2021) Xucheng Hou et al. Nature Reviews Materials
- 958 BNT211: a phase I/II trial to evaluate safety and efficacy of CLDN6 CAR-T cells and vaccine-mediated in vivo expansion in patients with CLDN6-positive advanced solid tumors
- (2021) Andreas Mackensen et al. Journal for ImmunoTherapy of Cancer
- mRNA-Based Cancer Vaccines: A Therapeutic Strategy for the Treatment of Melanoma Patients
- (2021) Maryam Bidram et al. Vaccines
- Results of the ADAPT phase 3 study of Rocapuldencel-T in combination with sunitinib as first-line therapy in patients with metastatic renal cell carcinoma
- (2020) Robert A. Figlin et al. CLINICAL CANCER RESEARCH
- TriMix and tumor antigen mRNA electroporated dendritic cell vaccination plus ipilimumab: link between T-cell activation and clinical responses in advanced melanoma
- (2020) Brenda De Keersmaecker et al. Journal for ImmunoTherapy of Cancer
- Once, Twice, Three Times a Finding: Reproducibility of Dendritic Cell Vaccine Trials Targeting Cytomegalovirus in Glioblastoma
- (2020) Kristen A Batich et al. CLINICAL CANCER RESEARCH
- An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma
- (2020) Ugur Sahin et al. NATURE
- Recent developments of RNA-based vaccines in cancer immunotherapy
- (2020) Elnaz Faghfuri et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- mRNA vaccine–induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer
- (2020) Gal Cafri et al. JOURNAL OF CLINICAL INVESTIGATION
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Turning the corner on therapeutic cancer vaccines
- (2019) Robert E. Hollingsworth et al. npj Vaccines
- Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer
- (2019) Alexandros Papachristofilou et al. Journal for ImmunoTherapy of Cancer
- Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery
- (2019) Piotr S. Kowalski et al. MOLECULAR THERAPY
- Local delivery of OX40L, CD80, and CD86 mRNA kindles global anti-cancer immunity.
- (2019) Ole Audun Werner Haabeth et al. CANCER RESEARCH
- A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer
- (2019) Martin Sebastian et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Safety of nivolumab in combination with dendritic cell vaccines in recurrent high-grade glioma.
- (2019) Katherine B. Peters et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase I multicenter study to assess the safety, tolerability, and immunogenicity of mRNA-4157 alone in patients with resected solid tumors and in combination with pembrolizumab in patients with unresectable solid tumors.
- (2019) Howard A. Burris et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase I study (E011-MEL) of a TriMix-based mRNA immunotherapy (ECI-006) in resected melanoma patients: Analysis of safety and immunogenicity.
- (2019) ANA Maria Arance Fernandez et al. JOURNAL OF CLINICAL ONCOLOGY
- Engineering dendritic cell vaccines to improve cancer immunotherapy
- (2019) Caleb R. Perez et al. Nature Communications
- mRNA vaccines — a new era in vaccinology
- (2018) Norbert Pardi et al. NATURE REVIEWS DRUG DISCOVERY
- B Cells Are the Dominant Antigen-Presenting Cells that Activate Naive CD4+ T Cells upon Immunization with a Virus-Derived Nanoparticle Antigen
- (2018) Sheng Hong et al. IMMUNITY
- Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems
- (2017) S Guan et al. GENE THERAPY
- Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
- (2017) Ugur Sahin et al. NATURE
- Beyond antigens and adjuvants: formulating future vaccines
- (2016) Tyson J. Moyer et al. JOURNAL OF CLINICAL INVESTIGATION
- Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
- (2016) Lena M. Kranz et al. NATURE
- Particle-mediated Intravenous Delivery of Antigen mRNA Results in Strong Antigen-specific T-cell Responses Despite the Induction of Type I Interferon
- (2016) Katrijn Broos et al. Molecular Therapy-Nucleic Acids
- Systemic activation of antigen-presenting cells via RNA-loaded nanoparticles
- (2016) Elias J. Sayour et al. OncoImmunology
- Tumor neoantigens: building a framework for personalized cancer immunotherapy
- (2015) Matthew M. Gubin et al. JOURNAL OF CLINICAL INVESTIGATION
- Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large Animals
- (2015) Andreas Thess et al. MOLECULAR THERAPY
- Lipid-based mRNA vaccine delivery systems
- (2014) Patrick Midoux et al. Expert Review of Vaccines
- mRNA-based dendritic cell vaccines
- (2014) Daphné Benteyn et al. Expert Review of Vaccines
- A novel, disruptive vaccination technology
- (2013) Karl-Josef Kallen et al. Human Vaccines & Immunotherapeutics
- Selective uptake of naked vaccine RNA by dendritic cells is driven by macropinocytosis and abrogated upon DC maturation
- (2011) M Diken et al. GENE THERAPY
- Intradermal Vaccinations With RNA Coding for TAA Generate CD8+ and CD4+ Immune Responses and Induce Clinical Benefit in Vaccinated Patients
- (2010) Susanne M Rittig et al. MOLECULAR THERAPY
- Dendritic Cell-Based Cancer Gene Therapy
- (2009) Evelien L.J.M. Smits et al. HUMAN GENE THERAPY
- Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability
- (2008) Katalin Karikó et al. MOLECULAR THERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now